Concepedia

Richard D. Kim

RD

6

Publications

439

Citations

6

H-Index

2004

Active since

Affiliations

Moffitt Cancer Center(Current)

Center for Human Genetics

Massachusetts General Hospital

Samsung Medical Center

Clinica Universidad de Navarra

Richard D. Kim is an author at Moffitt Cancer Center specializing in tumor biology, pathology, and cancer cell biology.

Top concepts

Publications per year

2004–2023

6

Publications

6

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

Richard D. Kim, Debashis Sarker, Tim Meyer et al. · Cancer Discovery · 2019 · 239 citations · Full text

Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma

Megan Hatlen, Oleg Schmidt-Kittler, Cori Ann Sherwin et al. · Cancer Discovery · 2019 · 106 citations

Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors.

Mitesh J. Borad, Alison M. Schram, Richard D. Kim et al. · Journal of Clinical Oncology · 2023 · 35 citations

, , +16

Improving identification of differentially expressed genes in microarray studies using information from public databases

Richard D. Kim, Peter J. Park · Genome biology · 2004 · 33 citations · Full text

CrossChip: a system supporting comparative analysis of different generations of Affymetrix arrays

Sek Won Kong, Kyu‐Baek Hwang, Richard D. Kim et al. · Computer applications in the biosciences · 2005 · 16 citations · Full text

Rows per page

1–5 of 6